Effects of Unilateral Robotic Assistance on Compensation Strategies and Muscular Activity During Hemiparetic Gait
Launched by SPANISH NATIONAL RESEARCH COUNCIL · Nov 17, 2021
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
- Materials: The investigators have developed a Knee-Ankle-Foot orthosis (KAFO) composed of two joints aligned to the knee and ankle of the user. The length of its bars and the positions of its braces can be tailored to the anthropometry of different users. The knee joint is actuated by a DC brushless motor EC-60 flat 408057 (Maxon ag, Switzerland) coupled with a harmonic drive CSD-20-160-2AGR (Harmonic Drive LLC, EE.UU.). The transmission ratio of 1:60 of this system enables the application of a mean torque of 35Nm. The ankle joint of the prototype remains non-actuated and unlimited, enabl...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria Ischemic or haemorrhagic stroke that lead to hemiplegic gait
- Exclusion Criteria:
- • 1. Acute musculoskeletal diseases
- • 2. Peripheral vascular diseases
- • 3. Acute cardiopulmonary diseases
- • 4. Acute neurological diseases
- • 5. Excessive spasticity in any joint of the lower limb (Ashworth scale\> 2)
- • 6. Joint mobility restriction of lower limb joints due to any cause
- • 7. Pain due to impaired mobility of the lower limb
- • 8. Inability to use robotic exoskeleton prototypes due to his/her health condition.
About Spanish National Research Council
The Spanish National Research Council (CSIC) is Spain's largest public research institution, dedicated to advancing scientific knowledge and fostering innovation across various fields, including health, biotechnology, and social sciences. With a commitment to excellence in research and a focus on addressing societal challenges, CSIC supports numerous clinical trials aimed at improving public health outcomes. By collaborating with academic institutions, healthcare organizations, and industry partners, CSIC plays a pivotal role in translating scientific discoveries into practical applications, thereby enhancing the overall quality of life and contributing to the global scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
Julio S. Lora-Millan
Principal Investigator
Spanish National Research Council
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials